Original Articles Open access

Results of an observational retrospective multicenter study: “Campania INternal medicine - the Clinical INternist for heart failure”

Authors

Published
8 May 2023
Section
Original Articles
DOI
10.4081/itjm.2023.1594

Abstract

Introduction. The Campania population is characterized by a high incidence and prevalence of heart failure (HF). The aim of this study is to describe the clinical epidemiology, comorbidities, and treatments in HF patients admitted to Internal Medicine Wards (IMW) in Campania. Materials and Methods. It is a retrospective, regional, multicentric, observational study including patients admitted to 15 IMW in Campania, with an HF diagnosis, over a period of three consecutive months. Results. We identified 427 patients, stratified by ejection fraction (EF) category (127 EF≤40%; 216 EF 41-49%; 84 EF≥50%). In comparison with HFpEF subjects, patients with HFrEF were younger (74 years vs. 9 years), more commonly male (67% vs. 32%), and more likely to have an ischaemic aetiology (45% vs. 25%). The most used drugs at the time of hospitalization and after were Diuretics (80.3/93.5%), BBs (69.6/92.6%), and Statins (52.1/63.7%), with statistically significant pre-/post- differences (P≤0.05). Conclusions. EF is more likely to be non-preserved in younger males and in patients with CAD etiology. Hospitalization influences in a statistically significant way the change or adjustment of therapy for almost all drugs.

Keywords

References

  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131.
  2. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342-56. DOI: https://doi.org/10.1002/ejhf.1858
  3. Roger VL. Epidemiology of Heart Failure: A Contemporary Perspective. Circ Res 2021;128:1421-34. DOI: https://doi.org/10.1161/CIRCRESAHA.121.318172
  4. Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a communitybased cohort: 11-year follow-up of PREVEND. Eur Heart J 2013;34:1424-31. DOI: https://doi.org/10.1093/eurheartj/eht066
  5. Seferović PM, Vardas P, Jankowska EA, et al. The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019. Eur J Heart Fail 2021;23:906-14. DOI: https://doi.org/10.1002/ejhf.2143
  6. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28. DOI: https://doi.org/10.1056/NEJMsa0803563
  7. Cavaliere R, Gallucci F, Mathieu G. La prevenzione cardiovascolare nello Scompenso Cardiaco, in: Position paper FADOI sulla prevenzione cardiovascolare nei pazienti complessi a rischio. Quaderni Ital J Med 2015;3:339-55. DOI: https://doi.org/10.4081/itjm.q.2015.4
  8. Di Lenarda A, Scherillo M, Maggioni AP, et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study. Am Heart J 2003;146:E12. DOI: https://doi.org/10.1016/S0002-8703(03)00315-6
  9. Biagi P. Comorbidities and Outcome iN patients with chronic heart Failure: a study in INternal mEdicine units. Int J Cardiol 2011;152:88-94. DOI: https://doi.org/10.1016/j.ijcard.2011.02.025
  10. Verdiani V, Panigada G, Fortini A, et al. The heart failure in internal medicine in Tuscany: the SMIT Study. Ital J Med 2015;9:349-55. DOI: https://doi.org/10.4081/itjm.2015.554
  11. Gallucci F, Ronga I, Fontanella A, Uomo G. Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study. Ital J Med 2017;11:184-90. DOI: https://doi.org/10.4081/itjm.2017.705
  12. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail 2016;18:891-975. DOI: https://doi.org/10.1002/ejhf.592
  13. Savarese G, Stolfo D, Sinagra G, Lund LH. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol 2022;19:100-16. DOI: https://doi.org/10.1038/s41569-021-00605-5
  14. Hoffmann R, Barletta G, von Bardeleben S, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr 2014;27:292-301. DOI: https://doi.org/10.1016/j.echo.2013.12.005
  15. McGowan JH, Cleland JG. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003;146:388-97. DOI: https://doi.org/10.1016/S0002-8703(03)00248-5
  16. McNeer JF, Margolis JR, Lee KL, et al. The role of the exercise test in the evaluation of pa-tients for ischemic heart disease. Circulation 1978;57:64-70. DOI: https://doi.org/10.1161/01.CIR.57.1.64
  17. Sciomer S, Moscucci F, Salvioni E, Marchese G, et al. Role of gender, age and BMI in prog-nosis of heart failure. Eur J Prev Cardiol 2020;27:46-51. DOI: https://doi.org/10.1177/2047487320961980
  18. Scardovi AB, Petruzzi M, Rosano A, et al. Caratteristiche fenotipiche e strutturali dello scom-penso cardiaco nella donna [Heart failure phenotype in women]. G Ital Cardiol 2012;13:6S-11S.
  19. Crousillat DR, Ibrahim NE. Sex Differences in the Management of Advanced Heart Failure. Curr Treat Options Cardiovasc Med 2018;20:88. DOI: https://doi.org/10.1007/s11936-018-0687-y
  20. Garcia M, Mulvagh SL, Merz CN, et al. Cardiovascular Disease in Women: Clinical Perspectives. Circ Res
  21. ;118:1273-93.
  22. Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017;19:1574-85. DOI: https://doi.org/10.1002/ejhf.813
  23. Bellotti P, Badano LP, Acquarone N, et al. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore. Eur Heart J 2001;22:596-604. DOI: https://doi.org/10.1053/euhj.2000.2362
  24. Grigioni F, Carinci V, Favero L, et al. Hospitalization for congestive heart failure: is it still a cardiology business? Eur J Heart Fail 2002;4:99-104. DOI: https://doi.org/10.1016/S1388-9842(01)00204-5
  25. Auerbach AD, Hamel MB, Davis RB, et al. Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 2000;132:191-200. DOI: https://doi.org/10.7326/0003-4819-132-3-200002010-00004
  26. Maymon SL, Moravsky G, Marcus G, et al. Disparities in the characteristics and outcomes of patients hospitalized with acute decompensated heart failure admitted to internal medicine and cardiology departments: a singlecentre, retrospective cohort study. ESC Heart Fail 2021;8:390-8. DOI: https://doi.org/10.1002/ehf2.13084
  27. Gallucci F. Modelli a confronto nei percorsi gestionali dello scompenso cardiaco: l’esperienza campana. Quaderni Ital J Med 2021;9:e17.
  28. Dunlay SM, Redfield MM, Weston SA, et al. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 2009;54:1695-702. DOI: https://doi.org/10.1016/j.jacc.2009.08.019
  29. Dharmarajan K, Hsieh AF, Lin Z, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013;309:355-63. DOI: https://doi.org/10.1001/jama.2012.216476
  30. Gallucci F, Ferrara L, Mastrobuoni C, and Gruppo di Studio AGISCO. Aderenza alle racco-mandazioni prescrittive delle linee guida per il trattamento dello Scompenso Cardiaco: dati di uno studio osservazionale multicentrico (Studio AGISCO). XVI Congresso Regionale FADOI Campania. Napoli 28-29 settembre 2017. Ital J Med 2017;11:10-11.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2023 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.